REVIEW ARTICLE

THE SIGNIFICANCE OF MODIFIED PIRO SCORING WITH NLR BIOMARKER ON ENHANCING MORTALITY PREDICTION OF PATIENTS WITH VENTILATORS‑ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNIT

Tjokorda Gde Agung Senapathi, I Gede Budiarta, Putu Agus Surya Panji, Aida Aprilnita

Tjokorda Gde Agung Senapathi
Senior Lecturer, Department of Anesthesiology, Pain Management, and Intensive Care Medical Faculty of Udayana University – Sanglah General Hospital Denpasar - Bali

I Gede Budiarta
Senior Lecturer, Department of Anesthesiology, Pain Management, and Intensive Care Medical Faculty of Udayana University – Sanglah General Hospital Denpasar - Bali

Putu Agus Surya Panji
Senior Lecturer, Department of Anesthesiology, Pain Management, and Intensive Care Medical Faculty of Udayana University – Sanglah General Hospital Denpasar - Bali

Aida Aprilnita
Resident, Department of Anesthesiology, Pain Management, and Intensive Care Medical Faculty of Udayana University – Sanglah General Hospital Denpasar - Bali. Email: aidahanginputra@gmail.com
Online First: December 30, 2018 | Cite this Article
Senapathi, T., Budiarta, I., Panji, P., Aprilnita, A. 2018. THE SIGNIFICANCE OF MODIFIED PIRO SCORING WITH NLR BIOMARKER ON ENHANCING MORTALITY PREDICTION OF PATIENTS WITH VENTILATORS‑ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNIT. Bali Journal of Anesthesiology 2(3): 80-85. DOI:10.15562/bjoa.v2i3.94


Ventilator-associated pneumonia (VAP) is a pulmonary infection that occurs as a mechanical ventilator-related disease which accounts for almost 80% of hospital-acquired pneumonia with of high mortality rate, lengthens the hospital-stay rate and increases health costs. To provide a description of the likelihood of the patient's life expectancy, mortality, and prognosis of patients in ICU, a scoring system should be utilized in order to assess the severity of the disease and estimate mortality during hospital treatment. The PIRO scoring system is a comprehensive concept that provides good validity and derivation in predicting mortality risk in a wide range severity of the disease so that it is very useful in the selection or categorization of patients, especially those admitted to the ICU with VAP. A conjunction or integration with a simple biomarker such as Neutrophil-to-lymphocyte ratio (NLR) provides a better performance of the tool in regards to the predictive value in VAP mortality risk estimation. Since the NLR has a strong predictive value, is simple, low-cost, and easily available compared to other biomarkers, therefore it is practical and useful for prognostic indications for VAP with conjunction with the PIRO score where medical facilities are lacking.

References

Napolitano LM. Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital‐Acquired and Ventilator‐Associated Pneumonia. Clinical Infectious Diseases. 2010; 51(S1): 67–80. DOI: 10.1038/sj.emboj.7601311

CDC. Ventilator-Associated Event (VAE). Device-associated Events. 2018; 10: 1-55. Available from: https://www.cdc.gov/nhsn/PDFs/vae/Draft-Ventilator-Associate-Event-Protocol_v6.pdf.

Joseph NM, Sistla, S, Dutta TK, et al. Ventilator-Associated Pneumonia: A Review. European Journal of Internal Medicine. 2010; 21(5): 360-8. DOI: 10.1016/j.ejim.2010.07.006

SARI Working Group. A Strategy for the Control of Antimicrobial Resistance in Ireland. HSE Health Protection Surveillance Centre. Dublin: Health Protection Surveillance Centre; 2011. Available from: https://www.hpsc.ie/a-z/microbiology antimicrobialresistance/infectioncontrolandhai/guidelines/File,12530,en.pdf.

Khan F, Martin LI. The significance of clinical scores and biological markers in disease severity, mortality prediction, and justifying hospital admissions in patients with community-acquired pneumonia. Community Acquired Infection. 2016; 3(2): 36-42. DOI:10.4103/2225-6482.184909.

Vincent J, Moreno R. Clinical review: Scoring systems in the critically ill. Critical Care. 2010; 14(2): 207. DOI: 10.1186/cc8204.

Bouch DC, Thompson JP. Severity scoring systems in the critically ill. Continuing. Education in Anaesthesia, Critical Care & Pain. 2008; 8(5): 181-185. DOI: 10.1093/bjaceaccp/mkn033.

Haq A, Patil S, Parcells AL, et al. The Simplified Acute Physiology Score III is superior to the Simplified Acute Physiology Score II and Acute Physiology and Chronic Health Evaluation II in predicting surgical and ICU mortality in the “oldest old.” Current Gerontology Geriatrics Research. 2014; 934852: 1-9. DOI: 10.1155/2014/934852.

Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Critical Care Medicine. 1985; 13(10): 818‑29. DOI: 10.1097/00003246-198510000-00009

Macdonald S., Arendts G, Fatovich D, et al. Comparison of PIRO, SOFA, and MEDS Scores for Predicting Mortality in Emergency Department Patients with Severe Sepsis and Septic Shock. Society for Academic Emergency Medicine. 2014; 21(11): 1257–63. DOI: 10.1111/acem.12515

Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis‑related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis‑Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7): 707‑10. DOI: 10.1007/BF01709751

Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to Predict Outcome in Critically Ill Patients. JAMA. 2001; 286(14): 1754-58. DOI: 10.1001/jama.286.14.1754

Grissom CK, Brown SM, Kuttler KG, et al. A Modified Sequential Organ Failure Assessment (MSOFA) for critical care triage. Disaster Med Public Health Prep. 2010; 4(4): 277-84. DOI: 10.1001/dmp.2010.40.

Namendy SA, Medina MA, Barahona VG, et al. Application of modified sequential organ failure assessment score to critically ill patients. Braz J Med Biol Res. 2013; 46(2): 186-193. DOI: 10.1590/1414-431X20122308.

Rello J, Rodriguez A, Lisboa T, et al. PIRO score for community‑acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community‑acquired pneumonia. Critical Care Medicine. 2009; 37(2): 456‑62. DOI: 10.1097/CCM.0b013e318194b021.

Rosolem M, Rabello L, Leal J, et al. Understanding the PIRO concept: from theory to clinical practice – Part 2. Rev Bras Ter Intensiva. 2010; 22(1): 64-68. DOI: 10.1590/S0103-507X2010000100011.

Lisboa T, Diaz E, Sa-Borgez, et al. The ventilator-associated Pneumonia PIRO Score: A Tool for predicting ICU mortality and health-care resources use in ventilator-associated Pneumonia. CHEST. 2008; 134(6): 1208-16. DOl:lO.1378/chest.08-1106.

Howell M, Talmor D, Schuetz P, et al. Proof of principle: The predisposition, infection, response, organ failure sepsis staging system. Critical Care Medicine. 2011; 39(2): 322-27. DOI: 10.1097/CCM.0b013e3182037a8e

Krüger S, Frechen D, Ewig S. Prognosis of ventilator-associated pneumonia: What lies beneath. European Respiratory Journal. 2011; 37(3): 486–88. DOI: 10.1183/09031936.00123610.

Afifi M, Elhendy A, Eltaweel M, et al. Biomarker predictors of survival in patients with ventilator-associated pneumonia. Menoufia Medical Journal. 2015; 28(1): 254-8. DOI: 10.4103/1110-2098.156004.

Seligman R, Seligman BGS, Teixeira PJZ. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia. Jornal Brasileiro de Pneumologia : Publicaça̋o Oficial Da Sociedade Brasileira de Pneumologia e Tisilogia. 2011; 37(4): 495-503. DOI: S1806-37132011000400012 [pii].

Yang T, Wang C, Wang H, et al. The Prognostic and Risk Stratified Value of Neutrophil- Lymphocyte Count Ratio in Chinese Patients with Community-Acquired Pneumonia. European Journal of Inflammation. 2017; 15(1): 22–27. DOI: 10.1177/1721727X17702150

Forget P, Khalifa C, Defour J, et al. What is the normal Value of Neutrophil to Lymphocyte Ratio?. BMC Research Notes. 2017; 10(1): 1-4. DOI: 10.1186/s13104-016-2335-5.

Mohamed M, Mahgoub N, Osman S, et al. A.Reference Value of Neutrophil- Lymphocyte Ratio in Healthy Sudanese in Khartoum. Sch. J. App. Med. Sci. 2017; 5 (5C): 1915-19. DOI: 10.21276/sjams.

Kaya Y, Tas N, Cebeci Z, et al. Relation of Neutrophil To Lymphocyte Ratio With Presence and Severity of Pneumonia. Journal Of Clinical and Analytical Medicine. 2018; 9(5): 452-7. DOI: 10.4328/JCAM.5817

de Jager C, Wever PC, Gemen E, et al. The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia. PLoS ONE. 2012: 7(10): e46561. DOI:10.1371/journal.pone.0046561

Liu X, Shen Y, Ge Q, et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study. Mediators of Inflammation. 2016; 8191254: 1-8. DOI:10.1155/2016/8191254

Granja C, Póvoa P, Lobo C, et al. The Predisposition, Infection, Response, and Organ Failure (PIRO) Sepsis Classification System: Results of Hospital Mortality Using a Novel Concept and Methodological Approach. PLoS ONE. 2016: 8(1): e53885. DOI:10.1371/journal.pone.0053885


No Supplementary Material available for this article.
Article Views      : 184
PDF Downloads : 95